Randomised Trial of Two Versus Three Doses of Human Papillomavirus (HPV) Vaccine in India.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 16 Jan 2017
At a glance
- Drugs Human papillomavirus vaccine recombinant quadrivalent Merck (Primary)
- Indications Cervical cancer; Cervical intraepithelial neoplasia; Human papillomavirus infections
- Focus Adverse reactions; Pharmacodynamics
- 31 Aug 2016 Planned End Date changed from 1 May 2017 to 1 Jul 2021.
- 31 Aug 2016 Planned primary completion date changed from 1 May 2016 to 1 Jul 2019.
- 01 Dec 2015 Results published in the Lancet Oncology